Childhood cancer desperately needs more research.
Children's cancer is a rare disease, which means the market is small and pharmaceutical companies have few incentives to develop drugs for these cancers.
An injectable medication.
The maker of the EpiPen has raised the price of two injectable treatments to about US$600, six times the price nine years ago. Why do drug companies do this? Because they can. The FDA ends up helping.
Feel-good fudges designed to boost staff morale are giving way to tangible projects which can be reported to shareholders.
Even cheap dinners were found to influence prescribing habits.
An important new study in the United States has found doctors who receive just one cheap meal from a drug company tend to prescribe a lot more of that company's products.
What will happen to immigration, wages and the economy has been discussed at length. But the price of drugs may also be affected.
Oxycontin helped drive the opioid epidemic.
The sources of the opioid epidemic are complex, but one powerful motivator has been the pursuit of profit.
Martin Shkreli had victims long before he turned his hand to pharmaceuticals.
The lack of transparency and accountability found in the hedge fund world is increasingly finding a home in the pharmaceutical sector, where more people care.
Events disturbingly similar to the thalidomide tragedy continue to occur.
Tighter regulations of medicines and devices have prevented countless deaths and disabilities. But regulation can't always protect us from harm.
Taking off the label to charge more.
Pills by Shutterstock
Pharmaceutical companies aim to make a profit, but it took an industry insider to blow the whistle on some exorbitant drug costs the NHS was paying.
The goal is to grow and activate drugs by a process as simple as making tea.
This project offers the tantalising possibility that plants containing drugs, such as agents to treat HIV, could be farmed on a small scale at low cost by communities that need them most.
Bashing drugmakers can be an easy way to score political points.
Clinton, who named drug companies among her enemies in this week's debate, is pushing populist-inspired policies that could hamper the flow of new medicines.
Representatives of the 12 Trans-Pacific Partnership (TPP) member countries at a press conference in Atlanta, after a deal was reached.
EPA/Erik S. Lesser
Before the last round of negotiations, only a handful of issues remained in the way of concluding the TPP. A potential deal-breaker for Australia was intellectual property protections for biologics.
The future may not be as bleak as we thought.
Five new European studies say dementia occurrence is stable or falling. Our panic may have been unnecessary.
High costs are used to justify high drug prices.
Ever wonder how much it costs to develop a new drug? The Tufts Center for the Study of Drug Development estimates US$2.6 billion. But how accurate is this figure?
Changing views on depression.
New ideas about what depression is and how to treat it are being held back by a lack of commercial interest.
Drug reps form a huge part of the industry’s marketing strategy.
Here’s what I remember. It was 14 years ago, and I was a junior doctor working in psychiatry. Some colleagues planned a dinner as an end-of-term celebration and, despite reasonable incomes, they decided…
Pfizer can’t stop moving.
Pfizer is like Woody Allen’s famous shark. It has to keep moving or it will die. And the drug company seems unable to keep moving by any means other than acquisitions. Its all-time best-selling drug, Lipitor…
A new lab partnership.
Congratulations are in order. The pair have known each other for some time. But the relationship has now been formalised. Living as we do in modern times, both may have other relationships, but it’s still…
Designed for other uses.
Phil and Pam
Ever since the time of the guillotine, doctors have been at the centre of the death penalty. Joseph Guillotin, the physician who suggested the device be used in 18th-century France, was actually against…
Big pharma: a world of many faces.
With billions to be made on the back of ill health and notable scandals and cover-ups in its history, it’s fair to say that many see the public face of the pharmaceutical industry as a mask for darker…